Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN96,0396,213,90
Msft0,24
Nokia5,5025,6480,43
IBM0,50
Mercedes-Benz Group AG60,4560,470,68
PFE0,75
10.01.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 09.01.2026 22:00:00
Flora Growth Rg (NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
7,14 3,19 0,23 15 252
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 11.01.2026
Popis společnosti
Obecné informace
Název společnostiFlora Growth Corp
TickerFLGC
Kmenové akcie:Ordinary Shares
RICFLGC.O
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 31.12.2024 64
Akcie v oběhu k 28.11.2025 746 810
MěnaUSD
Kontaktní informace
Ulice3230 W. Commercial Boulevard, Suite 180
MěstoFORT LAUDERDALE
PSČ33309
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon14 168 612 267

Business Summary: Flora Growth Corp. is a cannabis company that manufactures and distributes consumer packaged goods and distributes medicinal cannabis and pharmaceutical products. Its brand consists of JustCBD, Vessel, Melo, Haze, and Australian Vaporizers. JustCBD is a consumer-packaged goods brand with over 350 products, including cannabidiol gummies, topicals, tinctures, and vape products. JustCBD products are available for purchase in smoke and vape shops, clinics, spas, and pet stores, as well as other independent non-traditional retail channels. Vessel is the cannabis accessory and technology brand servicing the United States and Canada through direct-to-consumer and retail sales. Vessel's products include cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herb categories, which are sold to consumers, dispensaries, smoke shops, and cannabis brands. Australian Vaporizers is an online retailer of vaporizers, hardware, and accessories in Australia.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Flora Growth Corp revenues decreased 11% to $36.3M. Net loss before extraordinary items decreased 18% to $6.8M. Revenues reflect House of Brands segment decrease of 20% to $12.2M, Commercial & Wholesale segment decrease of 6% to $26.5M, Germany segment decrease of 41% to $16.7M, United States segment decrease of 47% to $9.1M.
Odvětvová klasifikace
TRBC2012Medical Farming
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSMedicinal and Botanical Manufacturing
NAICSPharmaceutical Preparation Manufacturing
NAICSDrugs and Druggists' Sundries Merchant Wholesalers
NAICS2007Medicinal & Botanical Mfg
NAICS2007Pharmaceutical Preparation Mfg
NAICS1997Medicinal and Botanical Manufacturing
NAICS1997Pharmaceutical Preparation Manufacturing
SICMedicinals And Botanicals
SICPharmaceutical Preparations
SICDrugs/proprietaries/sundries



  • Poslední aktualizace: 11.01.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Executive Chairman of the BoardMichael Heinrich4220.09.202520.09.2025
Chief Executive Officer, DirectorDaniel Reis-Faria3620.09.202520.09.2025
Chief Financial OfficerDany Vaiman3925.06.2023